“We Need More Competition And Not Less To Address This Pandemic” WASHINGTON, D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement regarding today’s announcement by Gilead that it is withdrawing its request for extended monopoly rights on potential Covid-19 treatment remdesivir and will ask the FDA to revoke the drug’s special “orphan drug” […]

Continue Reading

President Trump Addressed the Need for Affordable Generic Drugs at the SOTU, Patent Reform is a Critical Component WASHINGTON, D.C. – The Coalition Against Patent Abuse (CAPA) released the following statement regarding the Trump administration’s efforts to tackle rising prescription drug prices caused by big pharmaceutical companies in his 2020 State of the Union address to […]

Continue Reading

Presidential Candidate Mike Bloomberg Proposes New Patent Reform Plan to Implement Long Overdue Patent Reforms IN CASE YOU MISSED IT: The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today regarding presidential candidate Mike Bloomberg’s new drug pricing plan that would […]

Continue Reading

Thanks Representatives Spanberger and Reed for introducing legislation to stop the big drug companies from using patent thickets to abuse the patent system and hurt patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today in […]

Continue Reading

Coalition organizes letter to Senators Coons and Tillis expressing significant concern that the STRONGER Patents Act would embolden Big Pharma to continue abusing the patent system and continue raising prices on prescription drugs WASHINGTON, D.C. –  Ahead of today’s Senate Judiciary Subcommittee hearing on the STRONGER Patents Act of 2019, over 20 organizations from across […]

Continue Reading

Thanks Committee members for highlighting the damaging impact of Big Pharma’s abuse of the U.S. patent system to maintain drug monopolies and prevent or delay generic alternative medications and life-saving treatments for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

Coalition urges Congress to reject harmful bill removing oversight review process currently used to protect against Big Pharma’s rampant patent abuse leading to significant higher prescription drug prices for patients WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates and others released the […]

Continue Reading

Applauds Senators Cornyn and Blumenthal for their efforts to stop the major drug companies from abusing the U.S. patent system to delay or prevent patients from accessing more affordable generic alternative medications and treatments. WASHINGTON, D.C. – The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading

Coalition calls on Congress to oppose “poison pill” bill that would undo significant Supreme Court rulings on patent abuse and ultimately lead to increased prescription drug prices and reduced access to life-saving treatments   WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market […]

Continue Reading

Thanks Senators Cornyn and Blumenthal for introducing legislation to crack down on major drug companies gaming the U.S. patent system to prevent or delay generic alternative medications and life-saving treatments for patients    WASHINGTON, D.C. –  The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free market advocates […]

Continue Reading